Semibranch Registry - Retrospective
Launched by UNIVERSITY HOSPITAL MUENSTER · Apr 15, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Semibranch Registry is a clinical trial that aims to study a new tool called the semibranch stent-graft, which is used in a procedure known as endovascular aortic repair. This procedure is designed to treat a condition called aortic aneurysm, where a blood vessel in the body becomes enlarged and poses a risk of bursting. The trial is currently looking for participants who are at least 18 years old and have already received treatment with this specific stent-graft.
If you or a family member qualifies for this study, you would be joining a group of individuals who have been treated with the semibranch stent-graft. While the trial is still in the recruiting phase, participants can expect to provide information about their treatment and health outcomes. This research is important because it will help doctors understand how well this new tool works and how it can improve care for patients with aortic aneurysms.
Gender
ALL
Eligibility criteria
- • Patient has been treated with the semibranch stentgraft
- • Patient is over 18 years old
About University Hospital Muenster
University Hospital Münster is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous investigations aimed at improving patient outcomes and developing new therapeutic strategies. With a strong focus on collaboration and ethical research practices, University Hospital Münster plays a pivotal role in translating scientific discoveries into practical applications, fostering a culture of inquiry that benefits both the medical community and the patients it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Münster, , Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported